These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8036014)

  • 21. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Osteopontin in tumor metastasis.
    Wai PY; Kuo PC
    J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells.
    Denhardt DT; Chambers AF
    J Cell Biochem; 1994 Sep; 56(1):48-51. PubMed ID: 7528752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
    Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
    Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin expression in mammary gland development and tumorigenesis.
    Rittling SR; Novick KE
    Cell Growth Differ; 1997 Oct; 8(10):1061-9. PubMed ID: 9342184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
    Chambers AF; Hota C; Prince CW
    Cancer Res; 1993 Feb; 53(3):701-6. PubMed ID: 8425206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin: possible role in prostate cancer progression.
    Thalmann GN; Sikes RA; Devoll RE; Kiefer JA; Markwalder R; Klima I; Farach-Carson CM; Studer UE; Chung LW
    Clin Cancer Res; 1999 Aug; 5(8):2271-7. PubMed ID: 10473115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
    Jin H; Valverde P; Chen J
    Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
    Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
    Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
    Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
    Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
    Marroquin CE; Downey L; Guo H; Kuo PC
    Immunol Lett; 2004 Aug; 95(1):109-12. PubMed ID: 15325806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN; Kang BB; Chen JH
    Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
    Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.
    Wu Y; Denhardt DT; Rittling SR
    Br J Cancer; 2000 Jul; 83(2):156-63. PubMed ID: 10901364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin: a protein with diverse functions.
    Denhardt DT; Guo X
    FASEB J; 1993 Dec; 7(15):1475-82. PubMed ID: 8262332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.